Drugmakers Argue Against Release of Phase I Clinical Trial Results

International Pharmaceutical Regulatory Monitor
A A
The UK BioIndustry Association and EuropaBio are calling for European regulators to drop plans to release Phase I clinical trial reports, saying the information they contain is commercially sensitive.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor